# China NMPA Inspection - Changsha Xinggongchang Biotechnology Co., Ltd. - June 26, 2019

Source: https://www.globalkeysolutions.net/records/china_inspection/changsha-xinggongchang-biotechnology-co-ltd/3acf4081-2059-433e-882c-9b5d291b7d5c/
Source feed: China

> China NMPA unannounced inspection for Changsha Xinggongchang Biotechnology Co., Ltd. published June 26, 2019. An unannounced inspection of Changsha Xinggongchang Biotechnology Co., Ltd. occurred on June 13-14, 2019. This supervision was conducted under the "Co

---

## Details

- Record Type: CHINA_INSPECTION
- Title: Notification of unannounced inspection of Changsha Xinggongchang Biotechnology Co., Ltd. (2019012)
- Company Name: Changsha Xinggongchang Biotechnology Co., Ltd.
- Publication Date: 2019-06-26
- Product Type: Cosmetics
- Summary: An unannounced inspection of Changsha Xinggongchang Biotechnology Co., Ltd. occurred on June 13-14, 2019. This supervision was conducted under the "Cosmetics Hygiene Supervision Regulations," "Key Points for Cosmetics Production License Inspection," and "Cosmetic Production Licensing Work Specifications." The inspection revealed several significant compliance issues.

Key violations included the absence of an annual training plan and employee assessment records. Infrastructure deficiencies were noted, specifically the lack of rodent-proof facilities for the exhaust fan in the finished product warehouse. Laboratory controls were found wanting, as a Bengal red agar culture medium lacked necessary supplier qualification certificates. Equipment management was also a concern, with a quantitative filling machine and a cigarette wrapping machine missing status markings, and a complete absence of maintenance, usage, or upkeep records for production equipment. Furthermore, hazardous materials, such as alcohol, were improperly stored alongside documents without designated areas or adequate fire-fighting provisions. Although materials like sodium hyaluronate requiring specific temperature storage were handled correctly, monitoring and recording of these conditions were not performed.

These findings represent non-compliance with the conditions for cosmetic production licensing. Consequently, the Hunan Provincial Drug Administration issued a rectification order, mandating that Changsha Xinggongchang Biotechnology Co., Ltd. address all identified deficiencies within a specified timeframe and submit a comprehensive rectification report upon completion.

Company: https://www.globalkeysolutions.net/companies/changsha-xinggongchang-biotechnology-co-ltd/3a0ebfcc-db8e-4fa0-b568-9d91af3ef58e/